Identification of a novel, selective GABA(A) alpha5 receptor inverse agonist which enhances cognition
by
Chambers MS, Atack JR, Broughton HB, Collinson N, Cook S,
Dawson GR, Hobbs SC, Marshall G, Maubach
KA, Pillai GV, Reeve AJ, MacLeod AM.
Merck Sharp & Dohme Research Laboratories,
The Neuroscience Research Centre,
Terlings Park, Eastwick Road,
Harlow, Essex, CM20 2QR, UK.
mark_chambers@merck.com
J Med Chem. 2003 May 22;46(11):2227-40

ABSTRACT

In pursuit of a GABA(A) alpha5-subtype-selective inverse agonist to enhance cognition, a series of 6,7-dihydro-2-benzothiophen-4(5H)-ones has been identified as a novel class of GABA(A) receptor ligands. These thiophenes have higher binding affinity for the GABA(A) alpha5 receptor subtype compared to the GABA(A) alpha1, alpha2, and alpha3 subtypes, and several analogues exhibit high GABA(A) alpha5 receptor inverse agonism. 6,6-Dimethyl-3-(2-hydroxyethyl)thio-1-(thiazol-2-yl)-6,7-dihydro-2-benzothiophen-4(5H)-one (43) has been identified as a full inverse agonist at the GABA(A) alpha5 receptor and is functionally selective over the other major GABA(A) receptor subtypes. 43 readily penetrates into the CNS to give selective occupancy of GABA(A) alpha5 receptors. In addition, 43 enhances cognitive performance in rats in the delayed 'matching-to-place' Morris water maze test-a hippocampal-dependent memory task-without the convulsant or proconvulsant activity associated with nonselective, GABA(A) receptor inverse agonists.

GABA
Vinpocetine
New brain cells
Centrophenoxine
The memory switch?
GABA-mediated inhibition
Anti-muscarinics/dumb-drug euphoria

Refs
and further reading

HOME
HedWeb
Nootropics
cocaine.wiki
Future Opioids
BLTC Research
MDMA/Ecstasy
Superhapiness?
Utopian Surgery?
The Abolitionist Project
The Hedonistic Imperative
The Reproductive Revolution
Critique of Huxley's Brave New World

The Good Drug Guide
The Responsible Parent's Guide
To Healthy Mood Boosters For All The Family